The Gingival Recession market, estimated at USD 3.56 Billion in 2025, is projected to exhibit a CAGR of 5.9% and reach USD 5.32 Billion by 2032.

Market growth is primarily driven by the rising prevalence of periodontal diseases, increasing geriatric population, and growing awareness regarding oral health and aesthetics. Advancements in minimally invasive surgical techniques, the adoption of regenerative dental procedures, and the availability of innovative biomaterials and grafting solutions are further supporting the market expansion.

Additionally, increased dental care expenditure, expanding clinical research for novel treatment approaches, and the rising number of dental visits in both developed and emerging economies are expected to drive the market growth over the forecast period.

Market Takeaways

• By Treatment Method, the Soft Tissue Grafting segment is projected to dominate the gingival recession market with a 40.5% share in 2025, driven by its high success rates, wide clinical adoption, and effectiveness in covering exposed roots and restoring gum aesthetics.
• By Product Type, Tissue Regenerative Materials are expected to lead the market with a 53.2% share in 2025, supported by the increasing use of collagen membranes, growth factors, and biomaterials to enhance tissue healing and regeneration.
• By End User, Hospitals are anticipated to capture the largest market share in 2025, owing to the availability of advanced dental surgery infrastructure, skilled periodontists, and a higher patient inflow for complex gingival procedures.
• By Region, North America is projected to hold the largest market share in 2025, supported by the rising prevalence of periodontal diseases, high dental care expenditure, early adoption of innovative dental procedures, and a strong presence of leading dental product manufacturers.

Gingival Recession Market Report Coverage

The full report is now available for purchase: https://www.coherentmi.com/industry-reports/gingival-recession-market

Market Dynamics

The gingival recession market is experiencing steady growth, driven by the rising prevalence of periodontal diseases, an increasing geriatric population, and heightened awareness of oral health and dental aesthetics. Growing patient preference for minimally invasive procedures and advancements in periodontal treatment techniques are enabling early intervention and improved clinical outcomes. Soft tissue grafting continues to be the most widely adopted approach, while regenerative procedures and the Pinhole Surgical Technique (PST) are gaining popularity due to faster recovery times and enhanced cosmetic results.

Innovation in biomaterials and regenerative solutions is a key market driver, with companies investing in tissue regenerative materials, growth factors, and bioactive membranes to enhance treatment efficacy and long-term success rates. Clinical research is further expanding the scope of novel grafting materials and minimally invasive approaches, which are expected to shape the future of gingival recession treatment. Additionally, increasing dental expenditure, rising dental tourism in emerging markets, and the expansion of specialized dental clinics are contributing to market growth.

In July 2024, BioCellgraft introduced OraFyl, a next-generation human connective tissue matrix (HCTM) therapy for soft and hard tissue enhancement. OraFyl is designed to address periodontal and general dental conditions, demonstrating significantly improved patient outcomes compared to current standard treatments. Clinical partners have successfully conducted multiple cases confirming OraFyl’s efficacy in managing periodontal disease, dental implants, gingival conditions, and other oral‑maxillofacial indications by treating the underlying soft and hard tissue deficiencies.

Market Trends

• “Skinification” of Dental Care & Holistic Aesthetics

An emerging trend in high-end cosmetic dentistry is the merging of dental care with skincare-inspired wellness treatments—termed “skinification.” Clinics are introducing multi-step oral therapies such as LED light treatments, gum serums, bacterial biofilm remediation, and even “oral detoxes,” all designed to promote both gum health and aesthetic enhancement. This shift reflects growing consumer demand for a wellness-driven, cosmetic approach to periodontal care, elevating gingival recession treatments beyond simple root coverage toward holistic facial aesthetics and preventive health.

In May 2024, according to an article published on Cosmetics Design Asia, consumers in China, Japan, and South Korea have increasingly embraced skincare-inspired oral care over the past few years. Brands such as Blispring, Colgate (China), and Gentist are incorporating skincare hero ingredients like hyaluronic acid, niacinamide, and probiotics into toothpastes and mouth gels. These formulations aim to nourish gums, reduce inflammation, and brighten teeth—essentially functioning as a skincare regimen for the mouth. This marks a clear extension of the “oral beauty” concept, transitioning from traditional oral hygiene toward dental wellness and aesthetics.

• Adoption of Regenerative & Biologic Treatments

Clinicians and patients are increasingly favoring biologic therapies—including platelet-rich fibrin (PRF), advanced PRF (A‑PRF), leucocyte‑PRF (L‑PRF), enamel matrix derivatives (EMD), and injectable tissue matrices—for managing gingival recession. These approaches are gaining popularity due to their minimally invasive nature, enhanced healing potential, and utilization of autologous or bioengineered materials.

A randomized controlled trial (RCT) published in BMC Oral Health in January 2025 evaluated A‑PRF combined with the VISTA technique for gingival recession treatment. The study demonstrated superior root coverage and increased keratinized gingiva thickness compared to the use of collagen matrices alone, highlighting improved soft tissue regeneration and reduced invasiveness with biologic adjuncts.

Market Opportunities

• Expansion in Dental Tourism & Cosmetic Dentistry

The growth of dental tourism is creating major opportunities for gingival recession treatments, especially in cosmetic and aesthetic periodontal care. Rising awareness of dental aesthetics is driving patients to seek high-quality procedures that improve both function and appearance. Patients from North America and Europe are increasingly traveling to India, Thailand, Mexico, and Eastern Europe for treatments like gum contouring, regenerative soft‑tissue grafts, and minimally invasive recession correction at significantly lower costs.

This demand is boosted by bundled dental tourism packages, which combine affordable treatment with travel experiences, and by social media influence, as consumers pursue “picture-perfect” smiles. Clinics in tourism-friendly regions are capitalizing on this trend by offering advanced technologies, regenerative materials, and aesthetic techniques to attract international patients.

• Integration of Digital Dentistry & 3D Printing

The integration of digital dentistry tools—including CBCT imaging, CAD/CAM systems, and intraoral scanning (IOS)—combined with 3D printing and AI-driven planning workflows, is ushering in a new era of precision periodontal treatment. This digital transformation enhances diagnosis, treatment planning, and surgical accuracy for soft‑tissue procedures such as gingival recession correction.

In August 2023 study published in the Journal of Clinical Medicine introduced a CBCT-based design workflow for fabricating patient-specific 3D‑printed scaffolds for periodontal regeneration. These customized grafts were precisely tailored to match osseous defects, marking a significant advancement toward personalized tissue engineering and improving outcomes in periodontium restoration.

Analyst View

• The gingival recession market is expected to witness steady growth over the next decade, supported by the rising prevalence of periodontal diseases, an aging global population, and the increasing focus on dental aesthetics. Growing patient preference for minimally invasive and cosmetic periodontal procedures is reshaping treatment practices, while the adoption of innovative grafting solutions, regenerative biomaterials, and biologic therapies is expanding the market’s clinical scope.
• Key growth drivers include heightened oral health awareness, increasing dental care expenditure, and the rapid uptake of advanced treatment techniques such as the Pinhole Surgical Technique (PST), platelet-rich fibrin (PRF) therapies, and customized tissue regenerative materials. Technological innovations, including CBCT-guided planning, CAD/CAM workflows, intraoral scanning, and 3D printing of patient-specific grafts, are enabling precision treatment and enhancing clinical outcomes, further strengthening market demand.
• On the innovation front, biologic and regenerative materials like A‑PRF, L‑PRF, and enamel matrix derivatives (EMD) are gaining clinical traction due to their superior healing profiles and reduced post‑operative morbidity. The growing evidence base from randomized controlled trials (2023–2025) highlights these biologic approaches as viable alternatives to traditional connective tissue grafts, aligning with the market’s shift toward less invasive and more patient-friendly solutions.
• Regional dynamics favor strong growth in North America and Europe, driven by early adoption of advanced dental procedures, robust reimbursement for select periodontal surgeries, and the presence of leading dental product manufacturers. Meanwhile, Asia Pacific and Latin America are poised for the fastest growth, fueled by dental tourism, lower procedural costs, and the rapid expansion of specialized dental clinics catering to international patients seeking cosmetic and functional periodontal care.
• From an investment perspective, the market offers opportunities for companies that focus on digital dentistry integration, biologic product development, and aesthetic-driven treatment innovations. Partnerships with dental clinics in tourism-friendly regions and the commercialization of next-generation regenerative materials are expected to be key competitive strategies.
• Overall, analysts anticipate that the gingival recession market will continue to expand steadily through 2032, with the convergence of digital workflows, regenerative science, and global demand for aesthetic periodontal care creating a clear pathway for sustainable growth despite challenges such as high treatment costs and limited insurance coverage for cosmetic dental procedures.

Competitive Landscape

• Straumann Group
• Dentsply Sirona
• Geistlich Pharma
• Zimmer Biomet Dental
• BioHorizons
• Markman Biologics Corporation
• McGuire Institute
• Mesenchymal Stem Cells Research Institutes
• Ubiquinon (Coenzyme Q10) Research Institutes

Gingival Recession Market Segmentation

• By Treatment Method
• Soft Tissue Grafting
• Regenerative Procedures
• Pinhole Surgical Technique (PST)
• By Product Type
• Tissue Regenerative Materials
• Bone Grafting Materials
• By End User
• Hospitals
• Dental Clinics
• Research Institutes

Regional Insights

• North America
  • U.S.
  • Canada
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Europe
  • Italy
  • Germany
  • U.K.
  • Spain
  • France
  • Russia
  • Rest of Europe
• Asia Pacific
  • South Korea
  • India
  • Japan
  • China
  • Australia
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of the Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa